Inappropriate acetylation or phosphorylation of Tau contributes toloss of MT binding and the formation of insoluble Tau aggregates in Alzheimer's disease(AD) and related tauopathies. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.